

Where we come from
Although firmly rooted in Germany, today we are very much a growing global business. An integrated research and development company, we have an enviable track record of bringing effective pain treatments and state-of-the-art technologies to patients. Our high level of investment in R&D is testament to our unwavering commitment to innovation.


1947 Penicillin

1957 Thalidomide

1968 International expansion

1977 Tramal®

2001 Transtec®

2003 Zaldiar®

2007 Versatis®

2010 Palexia® retard

2013 Andrómaco

2014 Arcoxia®

2017 Zomig®
another major pain indication to our portfolio

2017 Adhesys Medical

2018 NexiumTM and VimovoTM
